rs28365848

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_006516.4(SLC2A1):​c.-390delA variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 220,588 control chromosomes in the GnomAD database, including 5,620 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4176 hom., cov: 26)
Exomes 𝑓: 0.19 ( 1444 hom. )

Consequence

SLC2A1
NM_006516.4 upstream_gene

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.718
Variant links:
Genes affected
SLC2A1 (HGNC:11005): (solute carrier family 2 member 1) This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]
SLC2A1-DT (HGNC:44187): (SLC2A1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 1-42959040-CT-C is Benign according to our data. Variant chr1-42959040-CT-C is described in ClinVar as [Benign]. Clinvar id is 297392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A1NM_006516.4 linkc.-390delA upstream_gene_variant ENST00000426263.10 NP_006507.2 P11166Q59GX2
SLC2A1-DTNR_033967.1 linkn.-8delT upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A1ENST00000426263.10 linkc.-390delA upstream_gene_variant 1 NM_006516.4 ENSP00000416293.2 P11166

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35091
AN:
151988
Hom.:
4175
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.162
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.208
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.223
GnomAD4 exome
AF:
0.190
AC:
13033
AN:
68482
Hom.:
1444
Cov.:
0
AF XY:
0.191
AC XY:
7055
AN XY:
36914
show subpopulations
Gnomad4 AFR exome
AF:
0.227
Gnomad4 AMR exome
AF:
0.204
Gnomad4 ASJ exome
AF:
0.195
Gnomad4 EAS exome
AF:
0.180
Gnomad4 SAS exome
AF:
0.202
Gnomad4 FIN exome
AF:
0.208
Gnomad4 NFE exome
AF:
0.185
Gnomad4 OTH exome
AF:
0.191
GnomAD4 genome
AF:
0.231
AC:
35119
AN:
152106
Hom.:
4176
Cov.:
26
AF XY:
0.234
AC XY:
17403
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.258
Gnomad4 AMR
AF:
0.249
Gnomad4 ASJ
AF:
0.230
Gnomad4 EAS
AF:
0.228
Gnomad4 SAS
AF:
0.209
Gnomad4 FIN
AF:
0.247
Gnomad4 NFE
AF:
0.210
Gnomad4 OTH
AF:
0.225
Alfa
AF:
0.0646
Hom.:
138
Bravo
AF:
0.230
Asia WGS
AF:
0.243
AC:
845
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dystonia 9 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Encephalopathy due to GLUT1 deficiency Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Childhood onset GLUT1 deficiency syndrome 2 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Jun 18, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

GLUT1 deficiency syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dystonic disorder Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary cryohydrocytosis with reduced stomatin Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Epilepsy, idiopathic generalized, susceptibility to, 12 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28365848; hg19: chr1-43424711; API